From Eurofins BioPharma Services

In This COVID-19 Special Issue:

  • Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
  • Eurofins holds a wealth of cGMP experience testing RNA based drugs
  • Eurofins Bioanalytical Services develops surrogate virus neutralising antibody detection assays against SARS-CoV-2
  • Targeting pro-inflammatory cytokines for COVID-19 therapy: Qualified cell-based assays for accelerated drug discovery
  • Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
  • Testing disinfectants for virucidal efficacy, a daily job at Eurofins!
Eurofins Newsletter Product Image 1-1